The European off-patent drug trade group Medicines for Europe has again shown its “strong support” for the unitary Supplementary Protection Certificate regulation, as ongoing negotiations are taking place in the European Council.
Regulatory Recap: Medicines For Europe Reiterates Support For ‘Bullet-Proof’ SPC Process
Also, More Regulatory News From Europe, The US, Switzerland, And Vietnam
Generics Bulletin reviews the latest developments in the regulatory arena across the globe.
